The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
分析师观点：在6位专家眼中的Ionis Pharmaceuticals
A comprehensive...6 analysts have expressed a variety of opinions on Ionis Pharmaceuticals (NASDAQ:IONS) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，6位分析师对Ionis Pharmaceuticals（纳斯达克：IONS）表达了不同的观点，从看好到看淡，意见多样。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下面的表格中，您将找到他们最近评级的摘要，揭示了过去30天情绪的变化，并与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.67, a high estimate of $77.00, and a low estimate of $60.00. A decline of 3.18% from the prior average price target is evident in the current average.
经过分析师分析，12个月的价格目标提供了洞见，平均目标为65.67美元，最高估计为77.00美元，最低估计为60.00美元。从之前的平均价格目标来看，目前的平均目标明显下降了3.18%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
A comprehensive...
关于...
登录免费看全文
登录/注册
资讯热榜
更新时间